Nooms Microdose GLP-1 Rx Program employs our SmartDose protocol, which takes a gentler approach, using smaller and sometimes slower increases to help reduce side effects
Practical management considerations include: Dose review: If the heart rate increase is dose-dependent and symptomatic, reducing the dose or slowing the titration schedule where permitted by the trial protocol may help mitigate the effect whilst preserving therapeutic benefit
Offer is for 2 monthly fills through December 31, 2026, then $349 per month for Wegovy 0.25 mg, 0.5 mg, 1 mg, 1.7 mg or 2.4 mg and $399 per month for Wegovy HD (semaglutide) injection 7.2 mg
This positioning is crucial, as it frames GLP-1 RAs not as first-line treatments but as important tools in a comprehensive management strategy
Meanwhile, telehealth companies that market these medications receive little scrutiny as they race toward a $100 billion industry valuation by the end of the decade